Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 32


Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.

Shao H, Mohamed EM, Xu GG, Waters M, Jing K, Ma Y, Zhang Y, Spiegel S, Idowu MO, Fang X.

Oncotarget. 2015 Dec 24. doi: 10.18632/oncotarget.6757. [Epub ahead of print]


A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688.

Kostakoglu L, Duan F, Idowu MO, Jolles PR, Bear HD, Muzi M, Cormack J, Muzi JP, Pryma DA, Specht JM, Hovanessian-Larsen L, Miliziano J, Mallett S, Shields AF, Mankoff DA; ACRIN 668 Investigative Team.

J Nucl Med. 2015 Nov;56(11):1681-9. doi: 10.2967/jnumed.115.160663. Epub 2015 Sep 10.


Molecular Testing in Anatomic Pathology and Adherence to Guidelines: A College of American Pathologists Q-Probes Study of 2230 Testing Events Reported by 26 Institutions.

Volmar KE, Idowu MO, Souers RJ, Nakhleh RE.

Arch Pathol Lab Med. 2015 Sep;139(9):1115-24. doi: 10.5858/arpa.2014-0513-CP.


De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.

Idowu MO, Chhatrala R, Siddiqui MB, Driscoll C, Stravitz RT, Sanyal AJ, Bhati C, Sargeant C, Luketic VA, Sterling RK, Contos M, Matherly S, Puri P, Siddiqui MS.

Liver Transpl. 2015 Nov;21(11):1395-402. doi: 10.1002/lt.24223.


Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.

Siddiqui MS, Cheang KL, Luketic VA, Boyett S, Idowu MO, Patidar K, Puri P, Matherly S, Stravitz RT, Sterling RK, Sanyal AJ.

Dig Dis Sci. 2015 Aug;60(8):2529-37. doi: 10.1007/s10620-015-3627-7. Epub 2015 Mar 18.


Turnaround time for large or complex specimens in surgical pathology: a College of American Pathologists Q-Probes study of 56 institutions.

Volmar KE, Idowu MO, Souers RJ, Karcher DS, Nakhleh RE.

Arch Pathol Lab Med. 2015 Feb;139(2):171-7. doi: 10.5858/arpa.2013-0671-CP.


Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.

Siddiqui MS, Fuchs M, Idowu MO, Luketic VA, Boyett S, Sargeant C, Stravitz RT, Puri P, Matherly S, Sterling RK, Contos M, Sanyal AJ.

Clin Gastroenterol Hepatol. 2015 May;13(5):1000-8.e3. doi: 10.1016/j.cgh.2014.10.008. Epub 2014 Oct 13.


Primary and secondary angiosarcoma of the breast.

Arora TK, Terracina KP, Soong J, Idowu MO, Takabe K.

Gland Surg. 2014 Feb;3(1):28-34. doi: 10.3978/j.issn.2227-684X.2013.12.03. Review.


Surgical pathology report defects: a College of American Pathologists Q-Probes study of 73 institutions.

Volmar KE, Idowu MO, Hunt JL, Souers RJ, Meier FA, Nakhleh RE.

Arch Pathol Lab Med. 2014 May;138(5):602-12. doi: 10.5858/arpa.2013-0099-CP.


Attenuation of sepsis-induced organ injury in mice by vitamin C.

Fisher BJ, Kraskauskas D, Martin EJ, Farkas D, Puri P, Massey HD, Idowu MO, Brophy DF, Voelkel NF, Fowler AA 3rd, Natarajan R.

JPEN J Parenter Enteral Nutr. 2014 Sep;38(7):825-39. doi: 10.1177/0148607113497760. Epub 2013 Aug 5.


Equivocal or ambiguous terminologies in pathology: focus of continuous quality improvement?

Idowu MO, Wiles A, Wan W, Wilkinson DS, Powers CN.

Am J Surg Pathol. 2013 Nov;37(11):1722-7. doi: 10.1097/PAS.0b013e318297304f.


Epidermal growth factor receptor in lung cancer: the amazing interplay of molecular testing and cytopathology.

Idowu MO.

Cancer Cytopathol. 2013 Oct;121(10):540-3. doi: 10.1002/cncy.21321. Epub 2013 Jun 18. No abstract available.


Targeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicine.

Dumur CI, Idowu MO, Powers CN.

Cancer Cytopathol. 2013 Feb;121(2):61-71. doi: 10.1002/cncy.21225. Epub 2012 Aug 7. Review.


Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type.

Zhao M, Sachs PC, Wang X, Dumur CI, Idowu MO, Robila V, Francis MP, Ware J, Beckman M, Rizki A, Holt SE, Elmore LW.

Cancer Biol Ther. 2012 Jul;13(9):782-92. Epub 2012 Jun 6.


Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation.

Berrie JL, Kmieciak M, Sabo RT, Roberts CH, Idowu MO, Mallory K, Chung HM, McCarty JM, Borrelli CA, Detwiler MM, Kazim AL, Toor AA, Manjili MH.

Transplantation. 2012 May 15;93(9):949-57. doi: 10.1097/TP.0b013e3182497561.


Pathologic diagnostic correlation with breast imaging findings: a College of American Pathologists Q-Probes study of 48 institutions.

Idowu MO, Hardy LB, Souers RJ, Nakhleh RE.

Arch Pathol Lab Med. 2012 Jan;136(1):53-60. doi: 10.5858/arpa.2011-0217-CP. Erratum in: Arch Pathol Lab Med. 2012 Mar;136(3):226. Hardy, Linday Bonner [corrected to Hardy, Lindsay Bonner].


CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.

Idowu MO, Kmieciak M, Dumur C, Burton RS, Grimes MM, Powers CN, Manjili MH.

Hum Pathol. 2012 Mar;43(3):364-73. doi: 10.1016/j.humpath.2011.05.005. Epub 2011 Aug 10.


Mutations in the BRCT binding site of BRCA1 result in hyper-recombination.

Dever SM, Golding SE, Rosenberg E, Adams BR, Idowu MO, Quillin JM, Valerie N, Xu B, Povirk LF, Valerie K.

Aging (Albany NY). 2011 May;3(5):515-32.


Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure.

Kmieciak M, Payne KK, Idowu MO, Grimes MM, Graham L, Ascierto ML, Wang E, Wang XY, Bear HD, Manjili MH.

J Transl Med. 2011 Mar 31;9:35. doi: 10.1186/1479-5876-9-35.


Elevated TRF2 in advanced breast cancers with short telomeres.

Diehl MC, Idowu MO, Kimmelshue KN, York TP, Jackson-Cook CK, Turner KC, Holt SE, Elmore LW.

Breast Cancer Res Treat. 2011 Jun;127(3):623-30. doi: 10.1007/s10549-010-0988-7. Epub 2010 Jul 13.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk